Chondroprotective action of salmon calcitonin in experimental arthropathies.
To assess whether calcitonin exerts an influence on cartilage, three models of arthropathies in rabbits--representing three different modes of cartilage destruction--were used: (1) corticosteroid administration (endocrinological disturbances model); (2) meniscectomy (mechanical stress model); and (3) immobilization of the hind leg (nutritional disorder model). After 12 weeks of methylprednisolone (MP) administration, the rabbit femur heads displayed cartilage erosions, marked decrease of glycosaminoglycans (GAG) content, and narrowing of joint spaces. Elevation of serum uronic acid, activity of alkaline phosphatase, and calmodulin content was evident. All these changes were minimal--close to normal--in the group treated for 12 weeks with MP + salmon calcitonin (sCT). Partial meniscectomy and hind leg immobilization caused statistically significant loss of GAG from the cartilage and narrowing of the knee joint space during the same experimental period, 12 weeks. In both these models the groups of rabbits treated simultaneously with sCT showed only insignificantly smaller joint spaces and GAG content. These results support our hypothesis of a chondroprotective property of calcitonin. However, the mechanism through which calcitonin influences joint cartilage remains unknown. A direct effect of calcitonin on cultivated chondrocytes, as well as the role of calmodulin, beta-endorphins, calcium, and interleukin-1 in the process are discussed.
Badurski
J E
JE
Department of Medicine and Rheumatology, District General Hospital, Bialystok, Poland.
Schwamm
W
W
Popko
J
J
Zimnoch
L
L
Rogowski
F
F
Pawlica
J
J
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D002116:Calcitonin / Q000627:therapeutic use*; D002147:Calmodulin / Q000097:blood; D002358:Cartilage, Articular / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D004195:Disease Models, Animal; D006025:Glycosaminoglycans / Q000032:analysis; D007103:Immobilization; D007592:Joint Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D008775:Methylprednisolone; D011817:Rabbits; D013314:Stress, Mechanical; D014574:Uronic Acids / Q000097:blood
D002147:Calmodulin; D006025:Glycosaminoglycans; D014574:Uronic Acids; C028815:salmon calcitonin; D002116:Calcitonin; D000469:Alkaline Phosphatase; D008775:Methylprednisolone